Lumos Diagnostics Holdings Limited (ASX:LDX)

ASX:LDX Revenue

In the fiscal year ending June 30, 2026, Lumos Diagnostics Holdings had annual revenue of $13.19M USD with 6.39% growth. Lumos Diagnostics Holdings had revenue of $6.12M in the half year ending December 31, 2025, with 121.26% growth.

• Revenue: $13.19M
• Revenue Growth: +6.39%
• P/S Ratio: 4.95
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 94.44M AUD

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	13.19M	792.00K	6.39%
Jun 30, 2025	12.40M	1.27M	11.40%
Jun 30, 2024	11.13M	596.00K	5.66%
Jun 30, 2023	10.54M	-1.10M	-9.42%
Jun 30, 2022	11.63M	-7.22M	-38.32%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 28, 2026

Data Sources Report a data error